Showing results (81-90 of 312) with videos related to
Sort By:
Pageof 32
Clinical Colorectal Cancer|July 31, 2016
Pretreatment Serum Folate Levels and Toxicity/Efficacy in Colorectal Cancer Patients Treated With 5-Fluorouracil and Folinic AcidMichael Yan, Cheryl Ho, Eric Winquist, et al.Investigational New Drugs|February 28, 2006
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug studyEric Winquist, Jennifer Knox, Jean-Pierre Ayoub, et al.Gynecologic Oncology|September 11, 2009
A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184Helen J Mackay, Anna Tinker, Eric Winquist, et al.The Laryngoscope|August 16, 2013
Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patientsJohn Yoo, Scott J Hamilton, Douglas Angel, et al.Cancer|November 20, 2009
A phase 2 study of platinum and gemcitabine in patients with advanced salivary gland cancer: a trial of the NCIC Clinical Trials GroupScott A Laurie, Lillian L Siu, Eric Winquist, et al.Investigational New Drugs|August 28, 2016
Sunitinib maintenance therapy after response to docetaxel in metastatic castration resistant prostate cancer (mCRPC)Sunil Parimi, Misha Eliasziw, Scott North, et al.Urologic Oncology|October 22, 2022
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancerMary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, et al.Investigational New Drugs|November 6, 2004
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98)Georg A Bjarnason, Danielle Charpentier, Ralph Wong, et al.The Canadian Journal of Urology|May 10, 2005
Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centresD Scott Ernst, Penny Brasher, Peter M Venner, et al.Current Oncology (Toronto, Ont.)|November 26, 2024
Clinical Outcome Patterns of Use of Radium-223 in Patients with Metastatic Castration-Resistant Prostate CancerColleen Mackenzie, Jasna Deluce, Morgan Black, et al.Pageof 32